missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ CD19 Recombinant Rat Monoclonal Antibody (6OMP31)

Rat Recombinant Monoclonal Antibody

$639.17 - $1120.94

Specifications

Antigen CD19
Clone 6OMP31
Concentration 1 mg/mL
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Applications Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity  
Catalog Number Mfr. No. Quantity Price Quantity  
740156T
View Documents
Invitrogen™
740156T
100 μL
Each for $1,120.94
Only null left
 
740156TXS
View Documents
Invitrogen™
740156TXS
20 μL
Each for $639.17
Only null left
 
Description

Description

Recombinant rat monoclonal antibodies are produced using in vitro expression systems. Recombinant antibodies are produced using specific genes that code for the desired antibodies. These genes are cloned into an expression vector and expressed in vitro. The advantages of recombinant antibodies include better specificity and lot-to-lot consistency. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.

CD19 is a member of the immunoglobulin superfamily, characterized by two Ig-like domains, and is expressed on B cells throughout all stages of development, excluding terminally differentiated plasma cells. It is also expressed on follicular dendritic cells and has been observed on myeloid leukemia cells, particularly those of monocytic lineage. CD19 is considered the earliest and broadest B cell-restricted antigen, and its expression is found in all B cell precursor leukemias. CD19 forms a multimolecular complex with CD21, CD81, Leu13, MHC class II, and the B cell receptor (BCR), playing a crucial role in B cell signaling. As a signal-amplifying coreceptor for the BCR, CD19 lowers the threshold for antigen receptor-dependent stimulation, allowing B cells to respond specifically and sensitively to various antigens through low-affinity antigen receptors. Signaling through CD19 induces tyrosine phosphorylation, calcium flux, and proliferation of B cells. Beyond its role as a BCR coreceptor, CD19 can also signal independently of BCR co-ligation, serving as a central regulatory component upon which multiple signaling pathways converge. This makes CD19 an important functional regulator of both normal and malignant B cell proliferation. Mutations in the CD19 gene can result in hypogammaglobulinemia, a condition characterized by low levels of immunoglobulins, while CD19 overexpression can lead to B cell hyperactivity. CD19 is expressed on 100% of peripheral B cells, as defined by the expression of kappa or lambda light chains, underscoring its significance in B cell function and immune regulation.
Specifications

Specifications

CD19
1 mg/mL
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
Unconjugated
Rat
RUO
PBS with 0.09% sodium azide; pH 7.4
P15391
930
Primary
Affinity chromatography
6OMP31
-20°C, Avoid Freeze/Thaw Cycles
Recombinant Monoclonal
Liquid
IgG2a κ
Human
Cd19
AW495831; B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Cd19; CD19 antigen; CD19 molecule; CVID3; differentiation antigen CD19; Leu-12; T-cell surface antigen Leu-12
Cd19
Antibody
Videos
SDS
missing translation for 'documents'

missing translation for 'documents'